Contineum Therapeutics, Inc. (CTNM)
Market Closed
16 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS) Primary $
7. 08
-0.82
-10.3797%
$
503.37M Market Cap
- P/E Ratio
- Div Yield
1.11M Volume
- Eps
$ 7.9
Previous Close 
Want to track CTNM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Contineum Therapeutics, Inc. Analysts
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Joel Beatty Baird | 21,463.51 | $296,625.75 | $151,639.72 | -$144,986.03 | -48.88% |
2026 © Marketlog. All Rights Reserved.
